Correlation Between Galectin Therapeutics and Inovio Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Galectin Therapeutics and Inovio Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Galectin Therapeutics and Inovio Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Galectin Therapeutics and Inovio Pharmaceuticals, you can compare the effects of market volatilities on Galectin Therapeutics and Inovio Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Galectin Therapeutics with a short position of Inovio Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Galectin Therapeutics and Inovio Pharmaceuticals.

Diversification Opportunities for Galectin Therapeutics and Inovio Pharmaceuticals

0.14

Correlation Coefficient

Galectin Therapeutics  Inovio Pharmaceuticals

Average diversification

The 3 months correlation between Galectin and Inovio is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Galectin Therapeutics and Inovio Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inovio Pharmaceuticals and Galectin Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Galectin Therapeutics are associated (or correlated) with Inovio Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inovio Pharmaceuticals has no effect on the direction of Galectin Therapeutics i.e., Galectin Therapeutics and Inovio Pharmaceuticals go up and down completely randomly.

Pair Corralation between Galectin Therapeutics and Inovio Pharmaceuticals

Given the investment horizon of 90 days Galectin Therapeutics is expected to under-perform the Inovio Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Galectin Therapeutics is 1.28 times less risky than Inovio Pharmaceuticals. The stock trades about -0.25 of its potential returns per unit of risk. The Inovio Pharmaceuticals is currently generating about -0.14 of returns per unit of risk over similar time horizon. If you would invest  1,201  in Inovio Pharmaceuticals on March 3, 2024 and sell it today you would lose (188.00) from holding Inovio Pharmaceuticals or give up 15.65% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Galectin Therapeutics  vs.  Inovio Pharmaceuticals

Galectin Therapeutics

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Galectin Therapeutics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak essential indicators, Galectin Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Inovio Pharmaceuticals

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Inovio Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Inovio Pharmaceuticals displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Galectin Therapeutics and Inovio Pharmaceuticals

The main advantage of trading using opposite Galectin Therapeutics and Inovio Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Galectin Therapeutics position performs unexpectedly, Inovio Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inovio Pharmaceuticals will offset losses from the drop in Inovio Pharmaceuticals' long position.

The idea behind Galectin Therapeutics and Inovio Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.